Hoffmann-La Roche

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Phase 3Recruiting900 people15 Sept 2025clinicaltrials.gov

A Study to Compare Different Doses of RO7795081 With Placebo or Semaglutide in People With Type 2 Diabetes

Phase 2Active, not recruiting330 people8 Aug 2025clinicaltrials.gov

NCT06982131

Phase 1Active, not recruiting40 people21 May 2025clinicaltrials.gov

NCT06965413

Phase 2Active, not recruiting285 people11 May 2025clinicaltrials.gov

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Phase 3Recruiting600 people27 Jan 2025clinicaltrials.gov

A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

CollaboratorPhase 2Completed447 people8 Oct 2024clinicaltrials.gov

NCT06624059

Phase 3Completed11 people2 Oct 2024clinicaltrials.gov

A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

CollaboratorPhase 2Completed469 people29 Jul 2024clinicaltrials.gov

NCT06047080

Phase 3Active, not recruiting1,130 people21 Sept 2023clinicaltrials.gov

NCT05849857

CollaboratorPhase 2Recruiting80 people9 May 2023clinicaltrials.gov

A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

Phase 3Active, not recruiting459 people4 Apr 2023clinicaltrials.gov

A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation

Phase 1/2Recruiting320 people29 Mar 2023clinicaltrials.gov

A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma

Phase 1/2Recruiting200 people18 Oct 2022clinicaltrials.gov

NCT05498896

CollaboratorPhase 2Active, not recruiting146 people12 Aug 2022clinicaltrials.gov

NCT05154123

CollaboratorPhase 1Completed29 people10 Dec 2021clinicaltrials.gov

NCT04980222

Phase 2Active, not recruiting46 people28 Jul 2021clinicaltrials.gov

NCT04914741

CollaboratorPhase 1/2Status unknown80 people7 Jun 2021clinicaltrials.gov

NCT04910568

CollaboratorPhase 1Recruiting186 people2 Jun 2021clinicaltrials.gov

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

Phase 1/2Recruiting316 people17 Mar 2021clinicaltrials.gov

NCT04790903

Phase 1Terminated50 people10 Mar 2021clinicaltrials.gov